Aprogen
Startup
We are an unparalleled biopharmaceutical company. Through long history of research based on fundamental science, we have accumulated multiple unique and innovative biological drug development technologies. The first antibody biosimilar that was approved in Korea in 2006 was developed and transferred out by our company. Furthermore, we have continuously improved our technologies and infrastructure for protein design, high efficiency cell lines, cell culture optimization, and pharmacological analysis such that we can compete with a leading-edge in amidst of global pharmaceutical companies.
Organization Category
Organization Industries
Biotechnology
Biotechnology Research
Pharmaceutical
Organization's Target Markets
Global
Operating Information
Operating Status:
ActiveEmployees:
More than 100Funding Stage:
Late StageTotal Funding $:
62M≈Valuation $:
1B≈
Organization Address
Seongnam-Si
545 Dunchon-daero, 상대원1동 Jungwon-gu, Seongnam-si, Gyeonggi-do, South Korea
South Korea
